EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Clearance of interstitial fluid (ISF) and CSF (CLIC) group‐part of Vascular Professional Interest Area (PIA), updates in 2022‐2023. Cerebrovascular disease and the failure of elimination of Amyloid‐β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy

Louise Kelly iD, Christopher Brown, Daniel Michalik, Cheryl A Hawkes, Roxana Aldea, Nivedita Agarwal, Rami Salib, Aiman Alzetani, Douglas W Ethell, Scott E Counts, Mony de Leon, Silvia Fossati und 14 weitere

Alzheimer's & Dementia · 2024

DOI: 10.1002/alz.13512 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Louise Kelly und 25 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK. Hauptthemen laut MEDLINE: Alzheimer Disease, Cerebral Amyloid Angiopathy, Cerebrovascular Disorders. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This editorial summarizes advances from the Clearance of Interstitial Fluid and Cerebrospinal Fluid (CLIC) group, within the Vascular Professional Interest Area (PIA) of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART). The overarching objectives of the CLIC group are to: (1) understand the age‐related physiology changes that underlie impaired clearance of interstitial fluid (ISF) and cerebrospinal fluid (CSF) (CLIC); (2) understand the cellular and molecular mechanisms underlying intramural periarterial drainage (IPAD) in the brain; (3) establish novel diagnostic tests for Alzheimer's disease (AD), cerebral amyloid angiopathy (CAA), retinal amyloid vasculopathy, amyloid‐related imaging abnormalities (ARIA) of spontaneous and iatrogenic CAA‐related inflammation (CAA‐ri), and vasomotion; and (4) establish novel therapies that facilitate IPAD to eliminate amyloid β (Aβ) from the aging brain and retina, to prevent or reduce AD and CAA pathology and ARIA side events associated with AD immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCerebral Amyloid AngiopathyCerebrovascular DisordersHumansAmyloid beta-PeptidesExtracellular FluidBrain

Stichwörter der Autor:innen

ARIAIPADISTAARTamyloidcerebrospinal fluidclearanceinterstitial fluid

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK.
  • Biomedical and Life Sciences, Lancaster University, Lancaster, UK.
  • Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland.
  • Neuroradiology section, Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, LC, Italy.
  • Leucadia Therapeutics Inc, Riverside, California, USA.
  • Dept. Translational Neuroscience, Dept. Family Medicine, Michigan State University, Grand Rapids, Michigan, USA.

ORCID-Profile: Louise Kelly

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Kelly, L., Brown, C., Michalik, D., Hawkes, C. A., Aldea, R., Agarwal, N., Salib, R., Alzetani, A., Ethell, D. W., Counts, S. E., de Leon, M., Fossati, S., Koronyo-Hamaoui, M., Piazza, F., Rich, S. A., Wolters, F. J., Snyder, H., Ismail, O., Elahi, F., …, & Carare, R. O. (2024). Clearance of interstitial fluid (ISF) and CSF (CLIC) group‐part of Vascular Professional Interest Area (PIA), updates in 2022‐2023. Cerebrovascular disease and the failure of elimination of Amyloid‐β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13512

Vancouver

Kelly L, Brown C, Michalik D, Hawkes CA, Aldea R, Agarwal N, et al. Clearance of interstitial fluid (ISF) and CSF (CLIC) group‐part of Vascular Professional Interest Area (PIA), updates in 2022‐2023. Cerebrovascular disease and the failure of elimination of Amyloid‐β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13512

BibTeX
@article{Kelly2024,
  author = {Kelly, Louise and Brown, Christopher and Michalik, Daniel and Hawkes, Cheryl A and Aldea, Roxana and Agarwal, Nivedita and Salib, Rami and Alzetani, Aiman and Ethell, Douglas W and Counts, Scott E and de Leon, Mony and Fossati, Silvia and Koronyo-Hamaoui, Maya and Piazza, Fabrizio and Rich, Steven A and Wolters, Frank J and Snyder, Heather and Ismail, Ozama and Elahi, Fanny and Proulx, Steven T and Verma, Ajay and Wunderlich, Hilary and Haack, Mareike and Dodart, Jean Cosme and Mazer, Norman and Carare, Roxana O},
  title = {Clearance of interstitial fluid (ISF) and CSF (CLIC) group‐part of Vascular Professional Interest Area (PIA), updates in 2022‐2023. Cerebrovascular disease and the failure of elimination of Amyloid‐β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  doi = {10.1002/alz.13512}
}
Kostenlos starten →